Marie‐Laure Risse
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
Papers in
- Hematology 34
- Multiple Myeloma Research and Treatments 34
- Oncology 20
- Peptidase Inhibition and Analysis 13
- Cancer Treatment and Pharmacology 4
- Co-authors
- Alexandre Santos (2 shared papers)Gilles Vassal (2 shared papers)F Pein (2 shared papers)Philippe Moreau (29 shared papers)Laurent Vernillet (1 shared paper)Alain Deroussent (1 shared paper)Alain Gouyette (1 shared paper)Valérie Boige (2 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Blood (5 papers)Hematological Oncology (2 papers)HemaSphere (2 papers)Future Oncology (2 papers)
- Partner nations
- FranceUnited StatesCzechia
In The Last Decade
Marie‐Laure Risse
39 papers receiving 734 citations
Peers
Comparison fields: 5 of 54
- Hematology 303
- Oncology 373
- Pharmacology 55
- Molecular Biology 353
- Genetics 43
Countries citing papers authored by Marie‐Laure Risse
This map shows the geographic impact of Marie‐Laure Risse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie‐Laure Risse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie‐Laure Risse more than expected).
Fields of papers citing papers by Marie‐Laure Risse
This network shows the impact of papers produced by Marie‐Laure Risse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie‐Laure Risse. The network helps show where Marie‐Laure Risse may publish in the future.
Co-authors
The 25 scholars most cited alongside Marie‐Laure Risse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans. | 2000 | 185 |
| 2 | 2003 | 89 | |
| 3 | 2005 | 75 | |
| 4 | 2019 | 55 | |
| 5 | 2017 | 54 | |
| 6 | 2000 | 36 | |
| 7 | 2013 | 34 | |
| 8 | 2021 | 33 | |
| 9 | 2020 | 23 | |
| 10 | 2021 | 20 | |
| 11 | 2022 | 14 | |
| 12 | 2020 | 13 | |
| 13 | 2022 | 11 | |
| 14 | 2023 | 11 | |
| 15 | 2020 | 10 | |
| 16 | 2021 | 10 | |
| 17 | 2021 | 8 | |
| 18 | 2022 | 8 | |
| 19 | 2021 | 7 | |
| 20 | 2024 | 7 |
About Marie‐Laure Risse
Marie‐Laure Risse is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 41 papers that have together received 755 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (34 papers), Peptidase Inhibition and Analysis (13 papers), Chronic Lymphocytic Leukemia Research (12 papers), Protein Degradation and Inhibitors (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Cancer Treatment and Pharmacology (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Hematology (303 citations), Oncology (373 citations), Pharmacology (55 citations), Molecular Biology (353 citations) and Genetics (43 citations). Marie‐Laure Risse has collaborated with scholars based in France, United States and Czechia. Frequent co-authors include Alexandre Santos, Gilles Vassal, F Pein, Philippe Moreau, Laurent Vernillet, Alain Deroussent, Alain Gouyette, Valérie Boige, Thierry Cresteil and Éric Raymond. Their work appears in journals such as Journal of Clinical Oncology, Blood, Hematological Oncology, HemaSphere and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.